Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T Kottke

Showing results (1-10 of 24) with videos related to

Pageof 3
Sort By:
Circulation|October 1, 1979
Survival after CABG in a nonrandomized populationR V Luepker, T Kottke
Minnesota Medicine|May 1, 1986
Doctors helping smokers. Real world tacticsJ R Hughes, T Kottke
International Journal of Bio-Medical Computing|July 1, 1991
Polychotomous multivariate models for coronary heart disease simulation. III. Model sensitivities and risk factor interventionsZ Q Zhuo, E Ackerman, L Gatewood, et al.
International Journal of Epidemiology|August 1, 1992
Body mass index and the initial manifestation of coronary heart disease in women aged 40-59 yearsC M Beard, A Orencia, T Kottke, et al.
Circulation|February 18, 1997
The multilevel compliance challenge: recommendations for a call to action. A statement for healthcare professionalsN H Miller, M Hill, T Kottke, et al.
Bioorganic & Medicinal Chemistry Letters|December 19, 2008
Potential utility of histamine H3 receptor antagonist pharmacophore in antipsychoticsY von Coburg, T Kottke, L Weizel, et al.
Inflammation Research : Official Journal of the European Histamine Research Society ... [Et Al.]|January 9, 2010
Search for histamine H4 receptor ligands in the group of 4-methylpiperazino amide derivativesT Karcz, J Handzlik, D Łażewska, et al.
International Journal of Bio-Medical Computing|July 1, 1991
Polychotomous multivariate models for coronary heart disease simulation. II. Comparisons of risk functionsZ Q Zhuo, E Ackerman, L Gatewood, et al.
International Journal of Bio-Medical Computing|February 1, 1991
Polychotomous multivariate models for coronary heart disease simulation. I. Tests of a logistic modelZ Q Zhuo, E Ackerman, L Gatewood, et al.
Bioorganic & Medicinal Chemistry Letters|August 24, 2010
Azole derivatives as histamine H3 receptor antagonists, part 2: C-C and C-S coupled heterocyclesM Walter, K Isensee, T Kottke, et al.
Pageof 3

Showing results (1-10 of 24) with videos related to

Sort By:
Pageof 3
Circulation|October 1, 1979
Survival after CABG in a nonrandomized populationR V Luepker, T Kottke
Minnesota Medicine|May 1, 1986
Doctors helping smokers. Real world tacticsJ R Hughes, T Kottke
International Journal of Bio-Medical Computing|July 1, 1991
Polychotomous multivariate models for coronary heart disease simulation. III. Model sensitivities and risk factor interventionsZ Q Zhuo, E Ackerman, L Gatewood, et al.
International Journal of Epidemiology|August 1, 1992
Body mass index and the initial manifestation of coronary heart disease in women aged 40-59 yearsC M Beard, A Orencia, T Kottke, et al.
Circulation|February 18, 1997
The multilevel compliance challenge: recommendations for a call to action. A statement for healthcare professionalsN H Miller, M Hill, T Kottke, et al.
Bioorganic & Medicinal Chemistry Letters|December 19, 2008
Potential utility of histamine H3 receptor antagonist pharmacophore in antipsychoticsY von Coburg, T Kottke, L Weizel, et al.
Inflammation Research : Official Journal of the European Histamine Research Society ... [Et Al.]|January 9, 2010
Search for histamine H4 receptor ligands in the group of 4-methylpiperazino amide derivativesT Karcz, J Handzlik, D Łażewska, et al.
International Journal of Bio-Medical Computing|July 1, 1991
Polychotomous multivariate models for coronary heart disease simulation. II. Comparisons of risk functionsZ Q Zhuo, E Ackerman, L Gatewood, et al.
International Journal of Bio-Medical Computing|February 1, 1991
Polychotomous multivariate models for coronary heart disease simulation. I. Tests of a logistic modelZ Q Zhuo, E Ackerman, L Gatewood, et al.
Bioorganic & Medicinal Chemistry Letters|August 24, 2010
Azole derivatives as histamine H3 receptor antagonists, part 2: C-C and C-S coupled heterocyclesM Walter, K Isensee, T Kottke, et al.
Pageof 3